Multiple congenital anomalies‐intellectual disability (MCA‐ID) and neuroblastoma in a patient harboring a de novo 14q23.1q23.3 deletion
- 24 March 2014
- journal article
- case report
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 164 (5) , 1310-1317
Abstract
Neuroblastoma is the most frequent extra cranial solid tumor in infants and children. Genetic predisposition to neuroblastoma has been suspected previously due to familial cases of sporadic NB and predisposition to NB in several syndromes. Here, we report on a de novo 14q23.1–q23.3 microdeletion in a male presenting with a neuroblastoma diagnosed at 9 months, and spherocytosis, congenital heart defect, cryptorchidism, hypoplasia of corpus callosum, epilepsy, and developmental delay. Myc‐associated‐factor X (MAX) haploinsufficiency could be regarded as the predisposing factor to NB. Indeed 14q deletion is a recurrent somatic rearrangement in NB and MAX somatic and germline loss of function mutation have recently been described in pheochromocytoma and paraganglioma. However, MAX was expressed in the tumor of the patient we report on and, accordingly, loss of heterozygosity, mutation, or promoter methylation were excluded. In addition, we discuss the potential involvement in the clinical spectrum presented by the patient of five of the deleted genes, namely DAAM1, PLEKHG3, SPTB, AKAP5, and ARID4A.Keywords
This publication has 47 references indexed in Scilit:
- Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromesAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2011
- A de novo 1.5 Mb microdeletion on chromosome 14q23.2‐23.3 in a patient with autism and spherocytosisAutism Research, 2011
- Cyclin-dependent Kinase-mediated Phosphorylation of RBP1 and pRb Promotes Their Dissociation to Mediate Release of the SAP30·mSin3·HDAC Transcriptional Repressor ComplexJournal of Biological Chemistry, 2011
- Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and gliomaProceedings of the National Academy of Sciences, 2009
- Copy number variation at 1q21.1 associated with neuroblastomaNature, 2009
- Somatic and germline activating mutations of the ALK kinase receptor in neuroblastomaNature, 2008
- Identification of Chromatin Remodeling Genes Arid4a and Arid4b as Leukemia Suppressor GenesJNCI: Journal of the National Cancer Institute, 2008
- Loss of AKAP150 perturbs distinct neuronal processes in miceProceedings of the National Academy of Sciences, 2008
- Identification of ALK as a major familial neuroblastoma predisposition geneNature, 2008
- Birth‐related characteristics, congenital malformation, maternal reproductive history and neuroblastoma: The ESCALE study (SFCE)International Journal of Cancer, 2007